Alayon, Exur B.

HRN: 29-29-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/13/2026
07/20/2026
IV
55mg
Q8hours
PCAP-C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: